MW
873.0 g/mol
Purity
>99%
Growth Hormone Axis
GHRP-6
Growth Hormone Releasing Hexapeptide
Synthetic hexapeptide growth hormone secretagogue
$55
Per vial · Research use only · COA available
Compound Profile
| Appearance | Lyophilized white powder |
| Molecular Weight | 873.0 g/mol |
| Amino Acids | 6 |
| Dosage | 10 mg |
| Volume | 5 mL |
| Solubility | Bacteriostatic or sterile water |
| Purity | ≥98% (HPLC-UV-MS verified) |
| Storage | −20°C long-term · 4°C short-term · Protect from light |
Amino Acid Sequence
His-DTrp-Ala-Trp-DPhe-Lys-NH2
COA, sterility, endotoxin, and heavy metal test results available upon request.
For Research Use Only. This product is not for human consumption, clinical use, or veterinary use. Must be 21+ to purchase. Not evaluated or approved by the FDA for any therapeutic use. Introduction into humans or animals is strictly prohibited by law.
Overview
About GHRP-6
GHRP-6 is one of the original synthetic growth hormone-releasing peptides, developed decades before newer-generation secretagogues like Ipamorelin. It is studied both for its ability to stimulate pulsatile GH release via the ghrelin receptor and for a distinct secondary property among GHRPs — pronounced orexigenic (appetite-stimulating) activity.
Mechanism of Action
How It Works
GHRP-6 acts as an agonist at the ghrelin receptor (GHS-R1a), stimulating GH release from anterior pituitary somatotrophs through a pathway independent of, but complementary to, GHRH signaling. Because it also engages hypothalamic ghrelin-receptor circuitry tied to hunger signaling, GHRP-6 is a common reference compound in appetite-stimulation research. Relative to newer, more selective GHRPs, research has documented comparatively greater elevation of cortisol and prolactin alongside GH release.
Scientific Literature
Research Highlights
Ghrelin receptor (GHS-R1a) agonism — pulsatile GH release from the pituitary
Pronounced orexigenic effect — reference compound in appetite-stimulation research
IGF-1 elevation studied downstream of pituitary GH secretion
Studied gastroprotective and cardioprotective properties in preclinical models
Reference compound for comparing receptor selectivity against newer GHRPs (e.g. Ipamorelin)
Documented cortisol and prolactin co-elevation — a key differentiator in comparative GHRP research
One of the earliest characterized synthetic GH secretagogues, foundational to GHRP research
Research Disclaimer: All research highlights are derived from published preclinical, in vitro, and animal studies. Results observed in laboratory models may not translate to human outcomes. Genfinite makes no claims regarding therapeutic efficacy. All products are sold strictly for scientific research purposes only.
Handling
Storage & Reconstitution
Dry Storage
Store lyophilized powder at −20°C, away from light and moisture. Do not open until ready to use. Shelf life is significantly extended by proper dry storage.
Reconstitution
Reconstitute using Bacteriostatic or sterile water. Add solvent slowly to the side of the vial and allow to dissolve gently. Do not shake vigorously.
Post-Reconstitution
Store reconstituted solution refrigerated at 4°C. Use within your laboratory's established timeframe. Do not refreeze after reconstitution.
